Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

GlaxoSmithKline eyes Indian deal

September 23, 2009
Sales and Marketing GSK, India

GlaxoSmithKline is said to be looking to buy an Indian firm, according to reports in one of the country's largest …

News

GSK encouraged by first H1N1 vaccines results

September 15, 2009
Sales and Marketing GSK, h1n1

Results from the first trial of GlaxoSmithKline's new pandemic swine flu vaccine have been revealed. A German study of 130 …

News

‘No shortcuts’ on H1N1 vaccine safety says GlaxoSmithKline

August 20, 2009
Research and Development, Sales and Marketing GSK, h1n1, vaccines

GlaxoSmithKline says the public need not doubt the safety of its vaccine against the H1N1 swine flu, which it is …

News

GSK starts first trials for H1N1 vaccine in Germany

August 17, 2009
Research and Development, Sales and Marketing GSK, h1n1, vaccines

GSK is to embark on the clinical development for its pandemic swine flu vaccine, completing enrolment into its first study …

News

Vernalis and GSK sign risk-sharing deal

August 7, 2009
Research and Development, Sales and Marketing Deals, GSK, Vernalis

Vernalis and GlaxoSmithKline have joined forces to work on a cancer treatment in a deal which could be worth more …

News

GSK to co-market Amgen’s osteoporosis drug in Europe

July 28, 2009
Sales and Marketing Amgen, Deals, GSK

GlaxoSmithKline has signed a major deal with Amgen to co-market its new osteoporosis treatment denosumab in Europe, Australia, New Zealand …

News

Manufacturing news in brief

July 27, 2009
Manufacturing and Production GSK

Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Takeda, Merrion Pharma, Cambridge Major, Dendreon and GlaxoSmithKline, …

News

Generic losses outweigh pandemic pluses for GSK

July 23, 2009
Sales and Marketing GSK

GlaxoSmithKline has reported a 2% fall in sales for the second quarter as growing generic competition in the US bites. …

News

Lupus drug shows surprise phase III success

July 23, 2009
Research and Development, Sales and Marketing Benlysta, GSK, HGS, Lupus

 GSK and Human Genome Sciences’ lupus drug Benlysta has surprised analysts by showing unexpectedly positive results in a pivotal late-stage …

News

NICE to reconsider GSK’s Tyverb

July 9, 2009
Research and Development, Sales and Marketing GSK, NICE, Tyverb

NICE is to reconsider Tyverb under its new lenient approach for end-of-life drugs, after GSK appealed its previous rejection of …

News

GSK signs arthritis drug development collaboration

June 25, 2009
Research and Development, Sales and Marketing Deals, GSK

GlaxoSmithKline and Oxford-based Chroma Therapeutics are linking up to identify small molecule therapeutics in a bid to combat conditions like …

News
Abbas Hussain

GSK to co-market generics with Dr. Reddy’s

June 17, 2009
Sales and Marketing Dr Reddy, GSK, em, generics

 GlaxoSmithKline will increase its reach into emerging markets with a new deal to co-market generics with Dr. Reddy’s.The Indian company …

News

GSK signs alliance to target Chinese flu market

June 9, 2009
Research and Development GSK

News

Major Glaxo accounts go to TBWA

June 9, 2009
Medical Communications, Sales and Marketing GSK

GlaxoSmithKline has chosen new agencies to handle some of it biggest consumer brands, including Nicorette and weight loss drug Alli. …

News

GSK signs oncology deal with UK biotech

May 18, 2009
Research and Development, Sales and Marketing GSK, Oxford Biotherapeutics

GSK has struck a deal with Oxford BioTherapeutics to develop therapies for primary, metastatic and recurring forms of cancer. The …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025